Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 2/2016

Open Access 01-06-2016 | Erratum

Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis

Authors: Anthony Bewley, Joseph Fowler, Helmut Schöfer, Nabil Kerrouche, Vincent Rives

Published in: Dermatology and Therapy | Issue 2/2016

Login to get access

Excerpt

In the original publication the Funding section incorrectly states that funding was received from Galderma UK. This should state that funding was received from Galderma. …
Metadata
Title
Erratum to: Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis
Authors
Anthony Bewley
Joseph Fowler
Helmut Schöfer
Nabil Kerrouche
Vincent Rives
Publication date
01-06-2016
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 2/2016
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-016-0111-z

Other articles of this Issue 2/2016

Dermatology and Therapy 2/2016 Go to the issue

Erratum

Erratum to: New Patient-Oriented Tools for Assessing Atrophic Acne Scarring

Original Research

A 10-Year Retrospective Analysis of Methyl Aminolevulinate Photodynamic Therapy Consultation at the Hospital de Braga

Original Research

Erythema of Rosacea Impairs Health-Related Quality of Life: Results of a Meta-analysis

Review

Systemic Treatment of Pediatric Psoriasis: A Review

Case Report

Schnitzler Syndrome: A Dramatic Response to Anakinra

Original Research

How People with Facial Acne Scars are Perceived in Society: an Online Survey
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits